Table 1.

Cohort description

			Overall Survival				Progression Free Survival
		N	3yr rate	+/− SE	Median (months)	Log rank p- value	3yr rate	+/− SE	Median (months)	Log rank p- value
All Patients		73	48.8%	5.9%	35.64	·	16.1%	4.4%	12.75	·
Gender
Male		55	41.7%	6.7%	27.84	0.0142	12.7%	4.5%	11.47	0.1194
Female		18	72.2%	10.6%	56.64		24.3%	11.0%	20.55
Age
<65		36	52.1%	8.4%	36.48	0.4957	16.2%	6.2%	13.14	0.8642
> 65		37	45.5%	8.3%	31.68		16.2%	6.1%	12.75
N stage
N0		19	72.9%	10.4%	87.48	0.0034	47.4%	11.5%	26.84	0.0023
N1		4	50.0%	25.0%	38.82		0.0%	·	10.02
N2		46	38.8%	7.2%	22.92		5.4%	3.6%	9.51
N3		4	50.0%	25.0%	27.42		0.0%	·	11.56
N0		19	72.9%	10.4%	87.48	0.0012	47.4%	11.5%	26.88	0.0014
N1		4	50.0%	25.0%	38.82		0.0%	·	10.02
N2/N3		50	39.4%	7.0%	22.92		5.0%	3.3%	10.56
N0		19	72.9%	10.4%	87.48	0.0005	47.4%	11.5%	26.84	0.0003
N+		54	40.3%	6.7%	22.92		4.6%	3.0%	9.51
AJCC Stage
1		2	100.0%	·	·	0.0483	100.0%	·	·	0.0533
2		6	100.0%	·	·	(all)	33.3%	19.3%	20.17	(all)
3		37	42.2%	8.3%	31.68	0.4708	12.2%	5.7%	11.76	0.4023
4		28	42.9%	9.4%	22.92	(3 v. 4)	10.7%	5.9%	9.40	(3 v. 4)
Photosensitizer
Photofrin		52	47.4%	7.0%	35.38	0.8275	14.7%	5.0%	11.61	0.9621
HPPH		21	47.6%	10.9%	32.59		19.1%	8.6%	14.78
Chemotherapy
None		6	33.3%	19.3%	5.90	0.1682	16.7%	15.2%	5.27	0.5778
Pre-Op Only		6	66.7%	19.3%	45.17		16.7%	15.2%	8.90
Post-Op Only		50	49.3%	7.2%	35.58		17.8%	5.5%	15.34
Pre & Post Op		11	36.4%	14.5%	22.70		9.1%	8.7%	8.84
Pre-Op Only or Post-Op Only		56	51.2%	6.7%	40.12	0.0335	17.7%	5.1%	14.92	0.2436
Pre- and Post-Op Chemo		11	36.4%	14.5%	22.70		9.1%	8.7%	8.84